Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer (Breast Cancer Research and Treatment, (2019), 175, 2, (339-351), 10.1007/s10549-019-05166-3)

Jangsoon Lee, Bora Lim, Troy Pearson, Kuicheon Choi, Jon A. Fuson, Chandra Bartholomeusz, Linda J. Paradiso, Thomas Myers, Debu Tripathy, Naoto T. Ueno

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer (Breast Cancer Research and Treatment, (2019), 175, 2, (339-351), 10.1007/s10549-019-05166-3)'. Together they form a unique fingerprint.

Medicine & Life Sciences